Skip to content
StockMarketAgent
Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

FRA/JCR stock hub

FRA/JCR has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

FRA/JCRis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
360M
Frankfurt Stock Exchange
Market data

Price

Recent price action with selectable time range.

FRA/JCRFRA/JCR
—
Loading chart…
In the news

Latest news · FRA/JCR

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROE-4.9
P25 n/aP50 n/aP75 n/a
ROIC-7.2
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All FRA/JCR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
161
Groups with data
11
Currency
JPY
Showing 161 of 161 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
Japan
Country code
DE
Employees
987
Employees Change
53%
Employees Change Percent
5.67
Enterprise value
EUR 562.8M
Exchange
Frankfurt Stock Exchange
Financial currency
JPY
First seen
2026-05-10
Industry
Pharmaceutical Preparations
Last refreshed
2026-05-10
Market cap
EUR 360M
Price
EUR 2.88
Price currency
EUR
Rev Per Employee
206,637.33x
Sic
2834
Symbol
fra/JCR
Website
https://www.jcrpharm.co.jp

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-3.68%
EV Earnings
-42.48x
EV/Sales
2.76x
P/B ratio
1.42x
P/S ratio
1.77x
PE Ratio10 Y
52.85x
PE Ratio5 Y
32.99x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

20
MetricValue
EBIT Margin
-14.99%
EBITDA Margin
-5.65%
Gross margin
70.45%
Gross Profit
EUR 143.7M
Gross Profit Growth
6.54%
Gross Profit Growth Q
0.02%
Gross Profit Growth3 Y
-0.65%
Gross Profit Growth5 Y
7.64%
Net Income
EUR -13.2M
Net Income Growth Q
-70.44%
Pretax Margin
-8.86%
Profit Margin
-6.5%
Profit Per Employee
EUR -13,424
ROA
-3.22
Roa5y
5.4
ROCE
-8.94
ROE
-4.86
Roe5y
12.04
ROIC
-7.18
Roic5y
14.27

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

9
MetricValue
Cagr1y
2.57%
Div CAGR10
-41.05%
Div CAGR3
21.71%
Div CAGR5
12.51%
EPS Growth Q
-70.15
Revenue Growth
7.17x
Revenue Growth Q
-2.52x
Revenue Growth3 Y
0.03x
Revenue Growth5 Y
7.52x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

17
MetricValue
Asset Turnover
EUR 0.34
Assets
EUR 615.5M
Cash
EUR 85M
Current Assets
EUR 316.7M
Current Liabilities
EUR 272.4M
Debt
EUR 285.8M
Debt Equity
EUR 1.13
Equity
EUR 253.9M
Interest Coverage
-15.64
Liabilities
EUR 361.6M
Long Term Assets
EUR 298.8M
Long Term Liabilities
EUR 89.2M
Net Cash
EUR -200.8M
Net Cash By Market Cap
EUR -55.79
Net Debt Equity
EUR 0.79
Tangible Book Value
EUR 237.4M
Tangible Book Value Per Share
EUR 1.95

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.16
Inventory Turnover
0.45
Net Working Capital
EUR 164.7M
Quick ratio
0.61
Working Capital
EUR 44.5M
Working Capital Turnover
EUR 0.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

9
MetricValue
Buyback Yield
2.06%
Dividend Growth
-9.52%
Dividend Growth Years
1%
Dividend per share
EUR 0.11
Dividend Years
3
Dividend Yield
3.79%
Ex Div Date
2026-03-30
Last Dividend
EUR 0.05
Payout Frequency
Semi-Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

32
MetricValue
1Y total return
2.56%
200-day SMA
3.5
50-day SMA
3.14
50-day SMA vs 200-day SMA
50under200
All Time High
4.62
All Time High Change
-37.66%
All Time High Date
2024-11-28
All Time Low
2.32
All Time Low Change
24.14%
All Time Low Date
2025-04-07
ATR
0.06
Ch YTD
-23.81
High
2.88
High52
4.22
High52 Date
2025-11-28
High52ch
-31.75%
Low
2.88
Low52
2.7
Low52 Date
2025-05-26
Low52ch
6.67%
Ma50ch
-8.37%
Price vs 200-day SMA
-17.69%
RSI
41.77
RSI Monthly
46.46
RSI Weekly
37.11
Sharpe ratio
0.28x
Sortino ratio
0.57
Total Return
5.85%
Tr YTD
-22.5
Tr1m
-4%
Tr1w
-4.64%
Tr3m
-13.82%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
EUR -30.6M
Operating margin
-14.99

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

5
MetricValue
Float
71,441,464%
Shares Insiders
0.63%
Shares Institutions
8.98%
Shares Qo Q
-0.03%
Shares Yo Y
-2.06%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

36
MetricValue
Average Volume
1.4x
Bv Per Share
2.06
Ch1m
-4
Ch1w
-4.64
Ch1y
-0.69
Ch3m
-15.29
Ch6m
-14.79
Change
-2.04%
Change From Open
0
Close
2.94
Days Gap
-2.04
Depreciation Amortization
18,980,563.5
Earnings Date
2026-05-13
EBIT
EUR -30.6M
EBITDA
EUR -11.5M
EPS
EUR -0.11
F Score
1
Fiscal Year End
March
Founded
1,975
Income Tax
EUR -4.9M
Is Primary Listing
0
Last Report Date
2025-12-31
Ma150
3.46
Ma150ch
-16.71%
Ma20
2.98
Ma20ch
-3.29%
Next Earnings Date
2026-05-13
Open
2.88
Payment Date
2026-06-26
Ppne
214,765,745.9
Price Date
2026-05-08
Ptbv Ratio
1.52
Revenue
203,951,048x
Tax By Revenue
-2.41x
Tr6m
-13.33%
Z Score
1.27
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

FRA/JCR dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+3.8%
$0.11 annual per share
Payout ratio
n/a
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+12.5%
1 consecutive years of growth
Total shareholder yield
+5.8%
Next ex-dividend date: 2026-03-30
Performance

FRA/JCR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+2.6%
S&P 500 1Y: n/a
3Y total return
n/a
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns FRA/JCR?

Insider, institutional, and short-interest positioning.

Institutional ownership
+9.0%
Share of float held by funds and institutions
Insider ownership
+0.6%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-2.1%
Negative means the company is buying back shares.
Technical

FRA/JCR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
41.8
Neutral momentum band
Price vs 200-day MA
-17.7%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
0.28
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About FRA/JCR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/JCR stock rating?

fra/JCR is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/JCR analysis?

The full report lives at /stocks/fra/JCR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/JCR?

The latest report frames fra/JCR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/JCR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.